This is the authors' abstract. We don't add key points for this paper.
Tuberculosis has taken on a new face in the context of emergent drug use. The combination of conditions such as HIV infection, hepatitis B or C, arising from the use of injectable drugs create serious problems in hospitals. In this new context, the authors analyze epidemiological aspects, predisposing factors, clinical expressions and therapeutic solutions for these cases, but also the programs that must be adopted to allow the control of this new worldwide challenge.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Mihălţan et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: